CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $91,000 | -69.4% | 18,924 | -62.9% | 0.00% | -100.0% |
Q3 2020 | $297,000 | +133.9% | 51,011 | +171.8% | 0.00% | – |
Q2 2020 | $127,000 | +15.5% | 18,770 | +8.8% | 0.00% | – |
Q1 2020 | $110,000 | +129.2% | 17,249 | +433.2% | 0.00% | – |
Q2 2019 | $48,000 | -82.0% | 3,235 | -36.1% | 0.00% | -100.0% |
Q1 2018 | $267,000 | -22.6% | 5,060 | -0.3% | 0.00% | -50.0% |
Q4 2017 | $345,000 | -20.5% | 5,073 | -3.6% | 0.00% | 0.0% |
Q3 2017 | $434,000 | -9.0% | 5,261 | +3.3% | 0.00% | -33.3% |
Q2 2017 | $477,000 | +49.5% | 5,093 | +1.7% | 0.00% | +50.0% |
Q1 2017 | $319,000 | +10.8% | 5,010 | +60.2% | 0.00% | -33.3% |
Q3 2015 | $288,000 | +14.7% | 3,127 | +9.7% | 0.00% | 0.0% |
Q2 2015 | $251,000 | +16.2% | 2,851 | -2.1% | 0.00% | +50.0% |
Q1 2015 | $216,000 | – | 2,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |